Cargando…
A polymer-based systemic hemostatic agent
Uncontrolled noncompressible hemorrhage is a major cause of mortality following traumatic injuries in civilian and military populations. An injectable hemostat for point-of-care treatment of noncompressible hemorrhage represents an urgent medical need. Here, we describe an injectable hemostatic agen...
Autores principales: | Gao, Yongsheng, Sarode, Apoorva, Kokoroskos, Nikolaos, Ukidve, Anvay, Zhao, Zongmin, Guo, Shihui, Flaumenhaft, Robert, Gupta, Anirban Sen, Saillant, Noelle, Mitragotri, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394519/ https://www.ncbi.nlm.nih.gov/pubmed/32775633 http://dx.doi.org/10.1126/sciadv.aba0588 |
Ejemplares similares
-
Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis
por: Zhao, Zongmin, et al.
Publicado: (2019) -
Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis
por: Gao, Yongsheng, et al.
Publicado: (2021) -
A polymer‐based systemic hemostat for managing uncontrolled bleeding
por: Gao, Yongsheng, et al.
Publicado: (2023) -
Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
por: Wu, Debra, et al.
Publicado: (2020) -
Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics
por: Glassman, Patrick M., et al.
Publicado: (2020)